Professor Sarfaraz Niazi Convinces the US Senate to Vote on Removing Interchangeable Status of Biosimilars.

/PRNewswire/ -- The US is the only country with two classes of biosimilars; an interchangeable status is awarded to approved biosimilars after extensive...

Related Keywords

United States ,University Of Illinois ,Illinois ,Utah ,Chicago ,Sarfaraz Niazi ,J Clin Pharm ,Lee Press ,Us Senate ,Us Congress ,Biological Price Competition ,Innovation Act ,Affordable Healthcare ,Professor Sarfaraz Niazi ,Biosimilar Red Tape Elimination Act ,Senator Lee ,Professor Niazi ,Biologics Price Competition ,Clin Pharm ,Novel351k ,Nc ,